T2 Biosystems, Inc. (TTOO) Stock Forecast

OTC Pink: TTOOAnalyst ratings, price target and estimates.

TTOO analyst forecast

as of October 21, 2026
Analyst consensus
Hold
3.00 / 5 from 1 analysts
Price target
$5.00
average of analyst targets
Upside to target
+624,900.0%
from the latest close
Next earnings
—
52-week range
$0.00 – $0.00

TTOO analyst ratings

1 analysts
Strong buy
00%
Buy
00%
Hold
1100%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

TTOO price target

Price $0.00Target $5.00
52-week low $0.0052-week high $0.00

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

TTOO earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; TTOO beat in 7 of 12.

What analysts expect from TTOO

1 analysts cover T2 Biosystems; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $5.00, 624,900.0% above the latest close of $0.00. T2 Biosystems beat the EPS estimate in 7 of the last 12 quarters.

Related: TTOO income statement, TTOO key metrics, TTOO chart. See the TTOO stock overview for the latest quote and news.

TTOO forecast FAQ

What is T2 Biosystems's price target?

The average analyst price target for T2 Biosystems is $5.00, 624,900.0% above the latest close of $0.00.

Is T2 Biosystems a buy, hold or sell?

Of 1 analysts covering T2 Biosystems, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

Does T2 Biosystems usually beat earnings estimates?

T2 Biosystems reported EPS at or above the analyst estimate in 7 of the last 12 quarters.

Diagnostics & Research: forecast